Abstract:The Staphylococcus sp . are a dominant part of the human skin microbiome and present across the body. Staphylococcus epidermidis is a ubiquitous skin commensal, while S . aureus is thought to colonize at least 30% of the population. S . aureus are not only colonizers but a leading cause of skin and soft tissue infections and a critical healthcare concern. To understand how healthy human skin may differentiate commensal bacteria, such as S . epidermidis , from the potential pathogen methicillin-resistant S . aureus (MRSA), we use ex vivo human skin models that allow us to study this host-bacterial interaction in the most clinically relevant environment. Our work highlights the role of the outer stratum corneum as a protective physical barrier against invasion by colonizing Staphylococci. We show how the structural cells of the skin can internalize and respond to different Staphylococci with increasing sensitivity. In intact human skin, a discriminatory IL-1β response was identified, while disruption of the protective stratum corneum triggered an increased and more diverse immune response. We identified and localized tissue resident Langerhans cells (LCs) as a potential source of IL-1β and go on to show a dose-dependent response of MUTZ-LCs to S . aureus but not S . epidermidis . This suggests an important role of LCs in sensing and discriminating between bacteria in healthy human skin, particularly in intact skin and provides a detailed snapshot of how human skin differentiates between friend and potential foe. With the rise in antibiotic resistance, understanding the innate immune response of healthy skin may help us find ways to enhance or manipulate these natural defenses to prevent invasive infection. How healthy human skin can differentiate between commensal bacteria that live harmoniously on our skin and those bacteria that have the potential to cause invasive infection, is of great interest. Here we use ex vivo human skin models to show how the outer layer of human skin resists bacterial invasion and that disruption of this layer leads to increased infection and inflammation. We show how colonization of both intact and disrupted skin by Staphylococcus aureus causes an increased IL-1β signaling compared to the commensal S . epidermidis . We show that tissue resident Langerhans cells are well positioned throughout the skin epidermis and that MUTZ-LCs can differentiate commensal from pathogen via IL-1β. This work identifies one of the subtle, yet effective, pathways by which human skin differentiates commensals and pathogens. Understanding these mechanisms could lead to potential new treatment and prevention targets, mechanisms by which we can enhance innate immunity.

Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections.

A Novel Lipopeptide From Skin Commensal Activates Tlr2/Cd36-P38 Mapk Signaling To Increase Antibacterial Defense Against Bacterial Infection

Staphylococcus epidermidis augments human β-defensin-3 synthesis through the transforming growth factor alpha-epidermal growth factor receptor cascade

Selective Antimicrobial Action Is Provided by Phenol-Soluble Modulins Derived from Staphylococcus epidermidis, a Normal Resident of the Skin

Cyclic-di-GMP Stimulates Keratinocyte Innate Immune Responses and Attenuates Methicillin-Resistant Staphylococcus Aureus Colonization in a Murine Skin Wound Infection Model

The Human Anionic Antimicrobial Peptide Dermcidin Induces Proteolytic Defence Mechanisms in Staphylococci.

Staphylococcus Epidermidis Antimicrobial Delta-Toxin (Phenol-Soluble Modulin-Gamma) Cooperates with Host Antimicrobial Peptides to Kill Group A Streptococcus.

Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides

Innate antimicrobial peptide protects the skin from invasive bacterial infection

Lipopeptide 78 from Staphylococcus Epidermidis Activates Β-Catenin to Inhibit Skin Inflammation.

Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus

Inflammatory Response Against Staphylococcus aureus via Intracellular Sensing of Nucleic Acids in Keratinocytes

Keratinocyte-derived Defensins Activate Neutrophil-Specific Receptors Mrgpra2a/b to Prevent Skin Dysbiosis and Bacterial Infection.

Tissue resident cells differentiate S . aureus from S . epidermidis via IL-1β following barrier disruption in healthy human skin

Small proline-rich proteins (SPRRs) are epidermally produced antimicrobial proteins that defend the cutaneous barrier by direct bacterial membrane disruption

S. epidermidis Rescues Allergic Contact Dermatitis in Sphingosine 1-Phosphate Receptor 2-Deficient Skin

Differential regulation of beta-defensin expression in human skin by microbial stimuli

Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis

New Mechanisms of Skin Innate Immunity: ASK1-mediated Keratinocyte Differentiation Regulates the Expression of Beta-Defensins, LL37, and TLR2.

Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes

571 Staphylococcal Lipopeptide Induces Beta-Catenin to Suppress TLR3-mediated Skin Inflammation in Diabetes